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Ji-Feng Feng1,2*, Ying Huang3 and Qi-Xun Chen1,2Abstract
Background: Recent studies have shown that the presence of systemic inflammation correlates with poor survival
in various cancers. The aim of this study was to determinate the prognostic value of the neutrophil lymphocyte
ratio (NLR) and the platelet lymphocyte ratio (PLR) in patients with esophageal squamous cell carcinoma (ESCC).
Methods: Preoperative NLR and PLR were evaluated in 483 patients undergoing esophagectomy for ESCC from
January 2005 to December 2008. The prognostic significance of both markers was then determined by both
uni- and multivariate analytical methods. Receiver operating characteristic (ROC) curves were also plotted to verify
the accuracy of NLR and PLR for survival prediction.
Results: High preoperative NLR (≥3.5 versus < 3.5, P = 0.039) and PLR (≥150 versus < 150, P < 0.001) were significantly
associated with poor overall survival in multivariate analysis. However, our study demonstrated a better
discrimination for the PLR in terms of hazard ratio(HR) than the NLR (HR = 1.840 versus HR = 1.339). Patients with
NLR ≥3.5 had significantly poorer overall survival compared to NLR <3.5 (35.4% versus 57.7%, P < 0.001). Patients
with PLR ≥150 also had significantly poorer overall survival compared to patients with PLR <150 (32.7% versus
63.5%, P < 0.001). The area under the curve (AUC) was 0.658 (95% confidence interval (CI): 0.610 to 0.706, P < 0.001)
for NLR and 0.708 (95% CI: 0.662 to 0.754, P < 0.001) for PLR, indicating that PLR was superior to NLR as a predictive
factor in ESCC.
Conclusions: Preoperative NLR and PLR were significant predictors of overall survival in patients with ESCC.
However, PLR is superior to NLR as a predictive factor in patients with ESCC.
Keywords: Esophageal cancer, Neutrophil lymphocyte ratio, Platelet lymphocyte ratio, Prognostic factor, Squamous
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Esophageal cancer (EC) is the eighth most common type
of cancer worldwide. In China, the crude mortality rate
of EC in 2005 was 15.2/100,000, which represented
11.2% of all cancer deaths and ranked as the fourth most
common cause of cancer death [1]. Although advances
have occurred in its multidisciplinary treatment, surgical* Correspondence: Jifzhejiang@gmail.com
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reproduction in any medium, provided the orresection remains the modality of choice [2]. The overall
five-year survival after surgical resection is poor; the rea-
son for that is the relatively late stage of diagnosis and
rapid clinical progression [3,4]. Therefore, assessing the
prognostic factors in EC will become more and more
important.
Over the past few decades, a number of prognostic
factors for EC have been identified, including depth of
invasion, lymph node metastasis, TNM stage and other
miscellaneous factors [5,6]. Recently, there is increasing
evidence that a systemic inflammatory response is of prog-
nostic value in various cancers [7,8]. C-reactive protein isd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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protein is not routinely measured as part of the preopera-
tive examination. The neutrophil to lymphocyte ratio
(NLR) and platelet to lymphocyte ratio (PLR) are other
markers, and some studies have shown elevated NLR or
PLR to be a significant prognostic factor in cancers [9-11].
However, few studies regarding NLR and PLR in EC are
available, and their rolesare still controversial.
Esophageal squamous cell carcinoma (ESCC) is the
most common pathological type of EC in China, in con-
trast to the predominance of adenocarcinoma in the
Western world [12]. Thus, the aim of this study was to de-
termine the prognostic value of NLR and PLR in ESCC.Table 1 The characteristics of the 483 patients grouped by N
Cases (number, %) NLR (number
<3.5
Gender
Female 72 (14.9) 51
Male 411 (85.1) 254
Age (years)
≤60 273 (56.5) 167
>60 210 (43.5) 138
Tumor length
≤3 138 (28.6) 117
>3 345 (71.4) 188
Tumor location
Upper 27 (5.6) 12
Middle 247 (51.1) 156
Lower 209 (43.3) 137
Vessel involvement
Negative 407 (84.3) 263
Positive 76 (15.7) 42
Perineural invasion
Negative 390 (80.7) 247
Positive 93 (19.3) 58
Differentiation
Well 71 (14.7) 42
Moderate 323 (66.9) 217
Poor 89 (18.4) 46
Depth of invasion
T1 87 (18.0) 81
T2 80 (16.6) 54
T3 265 (54.9) 154
T4 51 (10.5) 16
Nodal metastasis
Negative 274 (56.7) 199
Positive 209 (43.3) 106Methods
Patients
A retrospective analysis was conducted of 483 patients
with ESCC who underwent curative esophagectomy in
our department from January 2005 to December 2008.
All of the patients included in the analysis fit the criteria:
(1) ESCC confirmed by histopathology; (2) curative
esophagectomy with R0 resection (en bloc resection with
margins histologically free of disease); (3) at least six
lymph nodes examined for pathological diagnosis; (4)
surgery neither preceded nor followed by adjuvant chemo-
therapy and/or radiotherapy; and (5) preoperative NLR
and PLR obtained before esophagectomy. All subjectsLR and PLR

































Figure 1 Correlation between the NLR and PLR (r = 0.483,
P < 0.001). NLR, neutrophil lymphocyte ratio; PLR platelet
lymphocyte ratio.
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which was approved by the Ethical Committees of Zhejiang
Cancer Hospital, Hangzhou, China.
In our institute, patients were followed up at our out-
patient department every three to six months for the
first two years after resection, then annually. Recording
of medical history, physical examination and computed
tomography of the chest were performed during the
follow-up. Endoscopy was obtained in cases of clinically
indicated recurrence or metastasis. The last follow-up
was 30 November 2011.
Surgery
The standard surgical approach consisted of a limited
thoracotomy on the right side and intrathoracic gastric re-
construction (Ivor Lewis procedure) for lesions at the
middle/lower third of the esophagus. Upper third lesions
were treated by cervical anastomosis (McKeown proced-
ure). In our institute, two types of lymphadenectomy were
carried out as a standard procedure. The majority of pa-
tients underwent two-field lymphadenectomy. In this co-
hort of patients, thoracoabdominal lymphadenectomy was
performed, including the subcarinal, paraesophageal, pul-
monary ligament, diaphragmatic and paracardial lymph
nodes, as well as those located along the lesser gastric
curvature, the origin of the left gastric artery, the celiac
trunk, the common hepatic artery and the splenic artery.
Three-field lymphadenectomy was performed only if the
cervical lymph nodes were thought to be abnormal upon
preoperative evaluation.
NLR and PLR evaluation
Data on preoperative blood cell counts were extracted in
a retrospective fashion from the medical records. All
white blood cell and differential counts were taken
within one week prior to surgery. The NLR was defined
as the absolute neutrophil count divided by the absolute
lymphocyte count, and it was categorized into two groups
[13] (<3.5 and ≥3.5); similarly, PLR was defined as the ab-
solute platelet count divided by the absolute lymphocyte
count, and it was also categorized into two groups [10,11]
(<150 and ≥150).
Statistical analysis
Statistical analysis was conducted with SPSS 17.0 (SPSS
Inc., Chicago, IL, USA). The Pearson Chi squared test
was used to determine the significance of differences for
patients grouped by NLR and PLR. The overall cumula-
tive probability of survival was calculated by the Kaplan-
Meier method, and the difference was assessed by the
log-rank test. Univariateand multivariate analyses of Cox
regression proportional hazard model were performed to
evaluate the prognostic parameters for overall survival
with the enter method. HRs with 95% CIswere used toquantify the strength of the association between predic-
tors and survival. ROC curves were also plotted to verify
the accuracy of NLR and PLR for overall survival predic-




Among the 483 patients, 72 (14.9%) were women and
411 (85.1%) were men. The mean age was 59.1 ± 8.0 years,
with an age range from 34 to 80 years. All the clinicopath-
ologic characteristics were comparable between patients
grouped by NLR or PLR, as shown in Table 1. Our study
showed that NLR or PLR was associated with tumor size,
differentiation, depth of invasion and nodal metastasis. In
addition, there was a positive correlation between the
NLR and PLR (r = 0.483, P < 0.001) (Figure 1).
Prognostic factors
Univariate analyses showed that tumor length, differenti-
ation, vessel involvement, perineural invasion, depth of
invasion, nodal metastasis, NLR and PLR were predictive
of survival. Then multivariate analyses were performed
with the Cox proportional hazards model. In that model,
we demonstrated that differentiation (P = 0.015), depth
of invasion (P = 0.024), nodal metastasis (P < 0.001),
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prognostic factors (Table 2). However, our study dem-
onstrated a better discrimination for the PLR in terms
of HR than the NLR (HR = 1.840 versus HR = 1.339,
respectively).
Overall survival
The overall survival was 49.5% in our study. Patients
with NLR ≥3.5 had significantly poorer overall survival
compared to NLR <3.5 (35.4% versus 57.7%, P < 0.001)Table 2 Univariate and multivariate analyses in 483 patients




>60 49.5 1.075 (0.647-1.785)
Gender
Female 61.1 1.000
Male 47.4 1.437 (0.969-2.131)
Tumor location
Upper/Middle 53.6 1.000
Lower 44.0 1.262 (0.982-1.623)
Tumor length (cm)
≤3 66.7 1.000
>3 42.6 2.158 (1.564-2.977)
Vessel involvement
Negative 52.6 1.000
Positive 32.9 1.673 (1.228-2.279)
Perineural invasion
Negative 51.8 1.000
Positive 39.8 1.397 (1.036-1.884)
Differentiation
Well/Moderate 51.9 1.000
Poor 38.6 1.507 (1.114-2.040)
Depth of invasion
T1-2 68.0 1.000
T3-4 39.5 2.363 (1.746-3.199)
Nodal metastasis
Negative 65.0 1.000
Positive 29.2 2.795 (2.158-3.621)
NLR
<3.5 57.7 1.000
≥3.5 35.4 1.947 (1.513-2.506)
PLR
<150 63.5 1.000
≥150 32.7 2.245 (1.735-2.904)
CI, confidence interval; ESCC, esophageal squamouscell carcinoma; HR, hazard ratio(Figure 2A). Patients with PLR ≥150 also had signifi-
cantly poorer overall survival compared to patients with
PLR <150 (32.7% versus 63.5%, P < 0.001) (Figure 2B).ROC curve for overall survival prediction
The AUC was 0.658 (95% CI: 0.610 to 0.706, P < 0.001)
for NLR and 0.708 (95% CI: 0.662 to 0.754, P < 0.001)
for PLR, indicating that PLR was superior to NLR as a





































; NLR, neutrophil lymphocyte ratio; PLR, platelet lymphocyte ratio.
Figure 2 The overall survival grouped by NLR and PLR. Patients with NLR ≥3.5 had significantly poorer overall survival compared to NLR <3.5
(35.4% versus 57.7%, P < 0.001) (A). Patients with PLR ≥150 also had significantly poorer overall survival compared to patients with PLR <150
(32.7% versus 63.5%, P < 0.001) (B). NLR, neutrophil lymphocyte ratio; PLR, platelet lymphocyte ratio.
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To the best of our knowledge, this is one of the largest
studies to evaluate the value of NLR and PLR in predict-
ing prognosis for patients with ESCC. In addition, this is
the first study to show PLR as an independent prognos-
tic factor in patients with ESCC. Our study showed thatFigure 3 The ROC curves grouped by NLR and PLR. The ROC for
NLR is represented by the green line with an AUC = 65.8% with a
sensitivity of 49.6% and a specificity of 72.8%, and the ROC for PLR is
represented by the blue line with an AUC = 70.8% with a sensitivity
of 54.1% and a specificity of 79.5%. AUC, area under the curve; NLR,
neutrophil lymphocyte ratio; PLR, platelet lymphocyte ratio; ROC,
receiver operating characteristic.high preoperative NLR (≥3.5 versus < 3.5, P = 0.039) and
PLR (≥150 versus < 150, P < 0.001) were significantly asso-
ciated with poor overall survival in multivariate analysis.
However, our study demonstrated a better discrimination
for the PLR in terms of HR than the NLR (HR = 1.840 ver-
sus HR= 1.339, respectively). The AUC was 0.658 for NLR
and 0.708 for PLR, indicating that PLR was superior to
NLR as a predictive factor in patients with ESCC.
There is a strong linkage between inflammation and
cancer [7,8]. Systemic chemotherapy or radiation will in-
evitably have an impact on the systemic inflammation.
Thus, evaluation of NLR and PLR in neoadjuvant or
adjuvantchemoradiotherapy does not reflect the baseline
impact of systemic inflammation on clinical outcome in
EC patients. Therefore, in our study,we evaluate the po-
tential prognostic role of preoperative NLR and PLR in
patients undergoing esophagectomy for ESCC without
neoadjuvant or adjuvant treatment.
Cancer-related inflammation causes suppression of an-
titumor immunity by recruiting regulatory T cells and
activating chemokines, which results in tumor growth
and metastasis. The presence of both neutrophilia and
thrombocytosis tends to represent a nonspecific response
to cancer-related inflammation [14]. The mechanism be-
tween preoperative leukocytosis and neutrophilia and can-
cer remains unclear. However, cancer has been shown to
produce myeloid growth factors, such as granulocyte
colony-stimulating factor, tumor necrosis factor-alpha,
interleukin-1, and interleukin-6, which may influence
tumor-related leukocytosis and neutrophilia [15,16].
Preoperative NLR is inversely related to prognosis in
many cancers; however, its role in EC is still controversial.
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a high NLR is associated with tumor progression and poor
survival in patients with EC. However, Dutta et al. [17]
and Rashid et al. [13] showed that NLR does not correlate
with prognostic factors in EC. However, there have been
few studies regarding PLR in EC patients. Dutta et al. [17]
showed that PLR does not correlate with prognostic
factors in patients with EC. In our study, however, high
preoperative NLR (≥3.5 versus < 3.5, P = 0.039) and PLR
(≥150 versus < 150, P < 0.001) were significantly associated
with poor overall survival in multivariate analysis. In
addition, our study also demonstrated a better dis-
crimination for the PLR in terms of HR than the NLR
(HR = 1.840 versus HR= 1.339, respectively).
In the present study, the correlation between NLR and
PLR was determined. As expected, we found that there
was a positive correlation between the NLR and PLR
(r = 0.483, P < 0.001). Finally, ROC curves were also
plotted to verify the accuracy of NLR and PLR for sur-
vival prediction. The AUC was 0.658 (95% CI: 0.610 to
0.706, P < 0.001) for NLR and 0.708 (95% CI: 0.662 to
0.754, P < 0.001) for PLR, indicating that PLR was superior
to NLR as a predictive factor in patients with ESCC.
The potential limitations of the present study include
the use of a retrospective analysis and the short duration
of the mean follow-up duration. In addition, because the
study used data from a single institution but with differ-
ent pathologists and different surgeons, there may have
been a lack of uniformity. Furthermore, we excluded pa-
tients who had adjuvant chemotherapy and/or radiother-
apy, which may have influenced our analysis. Thus, larger
prospective studies will need to be performed to confirm
these preliminary results.
Conclusions
In summary, our study showed that preoperative NLR
and PLR are significant predictors of overall survival in
patients with ESCC. However, PLR is superior to NLR as
a predictive factor in patients with ESCC. Thus, larger
prospective studies will need to be performed to confirm
these preliminary results.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JFF conceived this study, collected data, performed the analysis and drafted
the manuscript. YH participated in study design, literature search and
coordination. JFF and YH performed data analysis and helped to draft the
manuscript. QXC participated in study design and helped to draft the
manuscript. All authors read and approved the final manuscript.
Author details
1Department of Thoracic Surgery, Zhejiang Cancer Hospital, No.38 Guangji
Road, Banshan Bridge, Hangzhou 310022, China. 2Key Laboratory Diagnosis
and Treatment Technology on Thoracic Oncology, Hangzhou 310022,
Zhejiang province, China. 3Department of Nursing, Zhejiang Cancer Hospital,
Hangzhou, China.Received: 12 July 2013 Accepted: 3 March 2014
Published: 19 March 2014
References
1. Zhao P, Dai M, Chen W, Li N: Cancer trends in China. Jpn J ClinOncol 2010,
40:281–285.
2. Wijnhoven BP, Tran KT, Esterman A, Watson DI, Tilanus HW: An evaluation
of prognostic factors and tumor staging of resected carcinoma of the
esophagus. Ann Surg 2007, 245:717–725.
3. Feng JF, Chen QX: Prognostic significance of preoperative CA72-4 in
patients with esophageal squamous cell carcinoma. Arch Iran Med 2013,
16:338–342.
4. Tachibana M, Kinugasa S, Hirahara N, Yoshimura H: Lymph node
classification of esophageal squamous cell carcinoma and
adenocarcinoma. Eur J CardiothoracSurg 2008, 34:427–431.
5. Feng JF, Huang Y, Zhao Q: Tumor length in elderly patients with
esophageal squamous cell carcinoma: is it a prognostic factor? Ups J Med
Sci 2013, 118:145–152.
6. Feng JF, Zhao Q, Chen QX: Prognostic value of subcarinal lymph node
metastasis in patients with esophageal squamous cell carcinoma. Asian
Pac J Cancer Prev 2013, 14:3183–3186.
7. Mantovani A, Allavena P, Sica A, Balkwill F: Cancer-related inflammation.
Nature 2008, 454:436–444.
8. Balkwill F, Mantovani A: Inflammation and cancer: back to Virchow?
Lancet 2001, 357:539–545.
9. Roxburgh CS, McMillan DC: Role of systemic inflammatory response in
predicting survival in patients with primary operable cancer. Future Oncol
2010, 6:149–163.
10. Sato H, Tsubosa Y, Kawano T: Correlation between the pretherapeutic
neutrophil to lymphocyte ratio and the pathologic response to
neoadjuvant chemotherapy in patients with advanced esophageal
cancer. World J Surg 2012, 36:617–622.
11. Sharaiha RZ, Halazun KJ, Mirza F, Port JL, Lee PC, Neugut AI, Altorki NK,
Abrams JA: Elevated preoperative neutrophil:lymphocyte ratio as a
predictor of postoperative disease recurrence in esophageal cancer.
Ann SurgOncol 2011, 18:3362–3369.
12. Corley DA, Buffler PA: Oesophageal and gastric cardia adenocarcinomas:
analysis of regional variation using the Cancer Incidence in Five
Continents database. Int J Epidemiol 2001, 30:1415–1425.
13. Rashid F, Waraich N, Bhatti I, Saha S, Khan RN, Ahmed J, Leeder PC, Larvin M,
Iftikhar SY: A pre-operative elevated neutrophil: lymphocyte ratio does
not predict survival from oesophageal cancer resection. World J
SurgOncol 2010, 8:1.
14. Bhatti I, Peacock O, Lloyd G, Larvin M, Hall RI: Preoperative hematologic
markers as independent predictors of prognosis in resected pancreatic
ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-
lymphocyte ratio. Am J Surg 2010, 200:197–203.
15. Kusumanto YH, Dam WA, Hospers GA, Meijer C, Mulder NH: Platelets and
granulocytes, in particular the neutrophils, form important
compartments for circulating vascular endothelial growth factor.
Angiogenesis 2003, 6:283–287.
16. Klinger MH, Jelkmann W: Role of blood platelets in infection and
inflammation. J Interferon Cytokine Res 2002, 22:913–922.
17. Dutta S, Crumley AB, Fullarton GM, Horgan PG, McMillan DC: Comparison
of the prognostic value of tumour- and patient-related factors in
patients undergoing potentially curative resection of oesophageal
cancer. World J Surg 2011, 35:1861–1866.
doi:10.1186/1477-7819-12-58
Cite this article as: Feng et al.: Preoperative platelet lymphocyte ratio
(PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive
factor in patients with esophageal squamous cell carcinoma. World
Journal of Surgical Oncology 2014 12:58.
